Current Issue

View Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences

Featured Articles

Navigating Technology Transfer

Current Status of Analytical Techniques for Characterization of Protein Stability

Dr. Sanket Patke, Research Investigator at Bristol-Myers Squibb with Dr. Joshua Stillahn and Dr Manning

Beyond Quality: PAT as a Catalyst for Carbon Reduction in Pharma

Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release

By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer

View All Featured Articles

Headline News

FDA grants Priority Review to BRUKINSA combination in first-line mantle cell lymphoma

Taltz and Zepbound combination maintains improved psoriatic arthritis outcomes at one year

Onchilles reports early systemic activity with intratumoral N17350 in Phase I/II trial

Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Identification of unknown extractables and leachables using mass spectrometry: Identification with confidence?

Presented by Petra Booij, Investigator at GlaxoSmithKline and Dr Kyle D’Silva, Pharma & BioPharma Marketing Leader, Thermo Fisher Scientific
30th January 2020

Using In-Vitro Dissolution to Support Post Approval Changes Global Regulatory Expectations

Presented by Xin Bu, Principal Scientist at Bristol-Myers Squibb
05th February 2019

Single-Use Technologies – The Perspective of an End User

Presented by Ciarán Kelleher, Senior Principal Engineer, Janssen and Barbara A Paldus, Chief Executive Officer of Finesse Solutions
25th March 2015

View All Past Webinars

Featured Companies

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

View All Videos